Virtus ETF Advisers LLC Fibrogen Inc Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$0.79 - $2.83 $471 - $1,689	-597 Reduced 9.0%	6,037 $5,000
Q2 2023 Aug 14, 2023	SELL	$2.49 - $20.59 $191 - $1,585	-77 Reduced 1.15%	6,634 $17,000
Q1 2023 May 15, 2023	SELL	$15.95 - $25.18 $41,214 - $65,065	-2,584 Reduced 27.8%	6,711 $125,000
Q4 2022 Feb 14, 2023	SELL	$13.27 - $17.73 $31,317 - $41,842	-2,360 Reduced 20.25%	9,295 $148,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $923 - $1,182	81 Added 0.7%	11,655 $152,000
Q2 2022 Aug 12, 2022	BUY	$7.94 - $12.96 $222 - $362	28 Added 0.24%	11,574 $122,000
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $8,221 - $11,484	-684 Reduced 5.59%	11,546 $139,000
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $39,650 - $61,452	3,993 Added 48.48%	12,230 $172,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $4,336 - $11,348	-426 Reduced 4.92%	8,237 $84,000
Q2 2021 Aug 10, 2021	BUY	$18.57 - $35.68 $34,038 - $65,401	1,833 Added 26.84%	8,663 $231,000
Q1 2021 May 17, 2021	BUY	$31.0 - $55.72 $3,441 - $6,184	111 Added 1.65%	6,830 $237,000
Q4 2020 Feb 12, 2021	SELL	$37.09 - $48.97 $50,256 - $66,354	-1,355 Reduced 16.78%	6,719 $249,000
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $44,597 - $50,141	-1,102 Reduced 12.01%	8,074 $332,000
Q2 2020 Aug 05, 2020	BUY	$32.57 - $42.83 $47,845 - $62,917	1,469 Added 19.06%	9,176 $372,000
Q1 2020 May 14, 2020	SELL	$23.3 - $45.96 $26,002 - $51,291	-1,116 Reduced 12.65%	7,707 $268,000
Q4 2019 Feb 13, 2020	BUY	$34.58 - $48.06 $90,046 - $125,148	2,604 Added 41.87%	8,823 $378,000
Q3 2019 Nov 12, 2019	SELL	$36.98 - $48.45 $12,795 - $16,763	-346 Reduced 5.27%	6,219 $230,000
Q2 2019 Aug 13, 2019	SELL	$35.13 - $55.53 $9,660 - $15,270	-275 Reduced 4.02%	6,565 $297,000
Q1 2019 May 14, 2019	SELL	$42.83 - $59.91 $35,548 - $49,725	-830 Reduced 10.82%	6,840 $372,000
Q4 2018 Feb 05, 2019	SELL	$37.97 - $60.16 $13,061 - $20,695	-344 Reduced 4.29%	7,670 $355,000
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $321,923 - $384,535	-5,718 Reduced 41.64%	8,014 $487,000
Q2 2018 Aug 10, 2018	SELL	$44.9 - $64.95 $203,307 - $294,093	-4,528 Reduced 24.8%	13,732 $860,000
Q1 2018 May 14, 2018	BUY	$45.35 - $61.65 $440,756 - $599,176	9,719 Added 113.79%	18,260 $844,000
Q4 2017 Feb 14, 2018	SELL	$41.95 - $60.1 $114,817 - $164,493	-2,737 Reduced 24.27%	8,541 $405,000
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $34,468 - $55,624	1,032 Added 10.07%	11,278 $607,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,246	10,246 $331,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account